SEC
AXSM icon

Seven Eight Capital’s Axsome Therapeutics AXSM Stock Holding History

Seven Eight Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,546
Closed -$948K – 58
2024
Q3 		$948K Buy
+10,546
New +$921K 0.09% 414
2023
Q2 		– Sell
-3,819
Closed -$236K – 493
2023
Q1 		$236K Sell
3,819
-9,071
-70% -$596K 0.05% 373
2022
Q4 		$994K Buy
12,890
+6,225
+93% +$372K 0.26% 126
2022
Q3 		$297K Buy
+6,665
New +$333K 0.06% 382
2022
Q1 		– Sell
-8,384
Closed -$317K – 522
2021
Q4 		$317K Sell
8,384
-18,816
-69% -$692K 0.06% 355
2021
Q3 		$897K Buy
+27,200
New +$1.06M 0.09% 330
2019
Q3 		– Sell
-8,818
Closed -$227K – 590
2019
Q2 		$227K Buy
+8,818
New +$177K 0.01% 548

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return